The Mechanism of Action of the Medication
Exploring the latest doctor-prescribed weight loss medication: Unveiling its mechanism of action, composition, recommended usage, and prescription rationale.
Dependable Medication You Can Rely On
The tailored solution: Compounded Semaglutide (GLP-1) – A unique, doctor-recommended weekly treatment customized for each patient. Unlocking fullness, the medication’s approach to replicating meal-induced hormonal responses, curbing appetite, delaying stomach emptying, and reducing caloric intake by targeting the brain. The body also has a “set point,” indicating the usual weight range it naturally stabilizes around. The treatment plan strives to establish a new, lower set point once you’ve reached your desired weight loss. Approximately 70% of adults in the United States are either obese or overweight, posing a substantial health concern closely linked to leading causes of mortality, including heart disease, stroke, and diabetes. Furthermore, it is correlated with an increased risk of developing certain types of cancer. Shedding between 5% to 10% of body weight through a blend of dietary modifications and physical activity has been associated with a reduced risk of cardiovascular disease in adults grappling with obesity or overweight conditions.
Introducing Compounded Semaglutide: Unveiling a Specialized Formulation
Compounded Semaglutide is an innovative variation of the medication semaglutide, belonging to the glucagon-like peptide-1 (GLP-1) receptor agonists class. Primarily prescribed for managing type 2 diabetes and aiding in blood sugar level reduction. Compounded Semaglutide has also demonstrated significant efficacy in weight loss management.
UNCOVER THE REASONS
Facing Challenges with Weight Loss? It's Not Your Fault.
“It’s not your fault!” These four words are some of the first ones I use when discussing the disease of obesity with a adult who has it, as well as their parents.
In many parts of the world, there has been a common misunderstanding that people with obesity are solely responsible for their condition because they eat too much and don’t exercise enough. This belief leads others to think that individuals with obesity are lazy and that all they need to do is eat less and exercise more. Unfortunately, growing up in a society that perpetuates these stereotypes can cause people with obesity to internalize these negative beliefs about themselves. However, this understanding of obesity is completely incorrect.
UNEARTH THE TIMING
A Ray of Hope Emerges.
On June 4, 2021, the FDA granted approval for a groundbreaking new category of weight-loss drugs, marking the first such approval in nearly a decade. This medication, known as Compounded Semaglutide or GLP-1, is formulated for the extended management of weight in individuals with a body mass index (BMI) of 27 kg/m2 or higher, accompanied by at least one weight-related medical condition. It is also suitable for those with a BMI of 30 kg/m2 or higher. Envision no longer contending with those hunger pangs that frequently sabotage your diet and contribute to weight gain. With this medication, you can anticipate enhanced well-being, a healthier lifestyle, and positive transformations in your overall health through weight loss. Esteemed sources such as The New York Times and prominent TV networks have labeled it a potential “holy grail” of weight loss. Even Dr. Oz has praised it as a groundbreaking, game-changing fat-busting drug.
Clinical Trials Show Positive Results
Clinical trials overseen by the U.S. Food & Drug Administration demonstrated that individuals using this remarkable drug experienced an average weight loss of approximately 15% of their body weight, equivalent to around 35 pounds. In the long term, the findings indicated even more substantial weight loss, with an average of 30%.
Seeking a Solution?
Act now—book your appointment today to discover how our FDA-approved, doctor-prescribed weight-loss medication can support you on your path to improved health and wellness!